Vicarious Surgical Inc. (RBOT) stock forecast summary
Our AI scores Vicarious Surgical Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Vicarious Surgical Inc. is a small-cap company with a market capitalization of $10K.
It ranks number 26 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.
Its ROE of -509.9% is the lowest of the 19 peers that report one.
For RBOT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -6.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does.
Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, RBOT included.
Price
RBOT price chart and AI forecast
RBOT
Cross-section · 2026-11-06
How RBOT ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Valuation & Market
Metric
RBOT
Industry median
Rank
Market Cap
$10K
$78M
26/26
EPS
$-8.19
–
–
Book Value/Share
$1.84
–
–
Profitability & Margins
Metric
RBOT
Industry median
Rank
ROE
-509.9%
-25.0%
19/19
ROA
-256.3%
-12.9%
19/19
Financial Health
Metric
RBOT
Industry median
Rank
Current Ratio
2.97x
2.55x
8/24
D/E Ratio
0.99x
0.77x
9/23
Financial Leverage
1.99x
1.77x
9/23
Interest Coverage
-3086.0x
-4.4x
19/20
Working Capital
$8M
$71M
17/24
Cash Flow
Metric
RBOT
Industry median
Rank
Operating Cash Flow
-$45M
-$680K
23/24
Income Statement
Metric
RBOT
Industry median
Rank
Operating Income
-$50M
-$7M
22/24
Net Income
-$50M
-$7M
19/20
R&D Expense
$34M
$20M
9/21
SG&A Expense
$34M
$182M
14/21
Dividend & Shareholder Information
Metric
RBOT
Industry median
Rank
Shares Outstanding
5M
–
–
Balance Sheet Highlights (USD millions)
Total Current Assets
$12M
Cash & Short-term Investments
$3M
Total Liabilities
$10M
Short-term Debt
$3M
Quarterly Financial Reports
RBOT quarterly financials and insider trading
Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Vicarious Surgical Inc. (RBOT) industry peers
Companies classified under the same SEC industry code as Vicarious Surgical Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
WALTHAM, Mass., March 30, 2026 (GLOBE NEWSWIRE)-- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the "Company"), ...
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ...
WALTHAM, Mass., March 16, 2026--(BUSINESS WIRE)--Vicarious Surgical Inc. (OTCID: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery, today announced a ...
More news available
Sign up free to read all 11 news articles and stay updated on market developments.
What is the Vicarious Surgical Inc. (RBOT) stock forecast?
Our AI scores Vicarious Surgical Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Vicarious Surgical Inc. stock predictions?
For RBOT, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -6.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Vicarious Surgical Inc. forecasts updated?
Vicarious Surgical Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Vicarious Surgical Inc.'s industry peers?
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
AI analystLive data
Intratio Assistant
Ask anything
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.